This study was undertaken to determine if changes in fibronectin biosynthesis accompany the phenotypic changes that occur in aortic tissue following experimental hypertension. An in vitro procedure was developed to measure fibronectin synthesis in aortic rings obtained from normotensive or hypertensive rats. There was a three to sixfold increase in fibronectin biosynthesis by aortic rings taken from rats treated with deoxycorticosterone/salt for 7 and 21 d, the change being more pronounced at 21 d. In contrast, there was no major change at either time point in net incorporation into total protein. Studies comparing fibronectin biosynthesis in aortic rings from Wistar rats and spontaneously hypertensive rats at ages between 10 and 40 wk showed increased fibronectin biosynthesis in older animals of both strains, but only slight differences between strains. Studies using rats infused with angiotensin II showed a correlation between blood pressure elevation and increased aortic fibronectin biosynthesis. Western blot analysis of aortic extracts showed that the fibronectin content was increased in the hypertensive models. The in vitro procedure for measuring fibronectin biosynthesis appears to provide a reliable reflection of in vivo changes in fibronectin expression, and the methodology could prove useful for studying the factors influencing protein expression in vascular tissue. (J. Clin. Invest. 1991Invest. . 88:1182Invest. -1189 
Introduction
Vascular complications of several diseases are associated with changes in the extracellular matrix and accompanying intracellular changes in vascular cells (1) . Since interactions between proteins of the extracellular matrix and cell receptors called integrins are known to influence cell structure, it is plausible that changes in the expression of components ofthe extracellular matrix could have a causative role in the development ofthe resulting vascular lesions. Several studies have indicated that vascular smooth muscle cells can undergo a change from a contractile to synthetic phenotype during atherosclerosis (2, 3) , and models for such changes have been established using cul-the extracellular matrix, was shown to interact with vascular smooth muscle cells in a manner influencing the interconversion between contractile and synthetic phenotypes (5) . Interactions between fibronectin and the endothelial cell also induce functional changes in motility, morphology, and replication (6) (7) (8) . Based on such studies performed with cultured cells, it is possible that fibronectin could modulate the function ofvascular cells and perhaps have a direct influence on the development of vascular lesions.
Histochemical studies have documented the presence of fibronectin in aortic tissue, and changes in fibronectin content have been reported in different disease states, such as diabetes and atherosclerosis (9) (10) (11) (12) (13) , although quantitation has been difficult due to the insoluble nature of the cellular fibronectin (14) . Recently, a study by Glukhova et al. (15) showed that different alternately spliced forms of fibronectin are selectively localized in the intima and media, and following either balloon injury to the rat aorta or in human aortic atherosclerotic lesions, a selective accumulation ofan alternatively spliced form of fibronectin was found within the intimal lesion.
Hypertension leads to morphological and functional changes in the vessel wall, and accompanying changes in the extracellular matrix have been documented (16) (17) (18) . However, there is little information available on changes in vascular fibronectin expression with hypertension. In a recent study ( 19) , we showed that steady-state mRNA levels for rat aortic fibronectin increased several-fold in deoxycorticosterone acetate (DOG)/ salt-treated and angiotensin II-infused rats and in the spontaneously hypertensive rat (SHR). An age-dependent increase in aortic fibronectin mRNA also was shown in those studies (19) . In this study, we have used an in vitro procedure for measuring protein biosynthesis in aortic rings to determine if the biosynthesis of aortic fibronectin is increased in experimental hypertension concomitant with the previously documented changes in steady state mRNA. In addition, Western blot analysis was used to measure the amount of fibronectin contained in aortic tissue from normotensive and hypertensive rats.
Methods
Animals. Male Wistar rats, 250-300 g, were obtained from Charles River Breeding Laboratories, Wilmington, MA. DOC/salt hypertension was induced as previously described (20) . Briefly, deoxycorticosterone pellets (100 mg) were implanted subcutaneously into uninephrectomized rats, and saline was substituted for drinking water. Control animals were uninephrectomized but not given DOC/salt treatment. Angiotensin II-induced hypertension was achieved by subcutaneous infusion of angiotensin II (125 ng/min) using an Alzet Mini-Osmotic pump. (Alza Corp., Palo Alto, CA). SHR were purchased from the Charles River Breeding Laboratories. Systolic blood pressure was mea-sured by tail cuff plethysmography and a photoelectric cell detector as described previously (21) .
Tissue. Animals were killed with an overdose of sodium pentobarbital. Aortae were removed, taking care to avoid stretching or compression of the tissue, and placed into ice-cold buffer containing 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4* H20, 1.4 mM KH2PO4 (pH 7.4), and 11 mM glucose. The region of the aorta extending from the arch to the diaphragm was used in all studies. Aortae were carefully cleaned of periadventitial tissue and seven to eight rings of -5 mm length were obtained from the arch and thoracic region of each aorta. The cleaning and preparation of rings were performed with care to avoid unnecessary damage to the vessel. The procedure routinely took -10 min per aorta. The rings prepared from a single rat aorta were placed into 2 ml ofDMEM without L-methionine (Gibco Laboratories, Grand Island, NY) that was supplemented with 8 MM L-methionine and 200 MACi "5S-methionine (New England Nuclear, Boston, MA). Incubations were at 370C for 5 h with constant shaking in an atmosphere of 95% air and 5% CO2. The aortic rings were removed from incubation media at the end ofthe incubation period, washed several times in PBS, and then weighed and frozen in liquid nitrogen. The weights of the aortic rings after incubation were considered as the aortic wet weight in the analysis of data. The incubation medium was stored at -700C.
Aortae were homogenized using a motor driven glass-glass apparatus in PBS containing aprotinin (50 trypsin inhibitory units/ml), leupeptin (10 mM), pepstatin A (1 mM), and PMSF (1 mM), at a 20:1 ratio ofbuffer volume to tissue wet weight. The homogenate was centrifuged at 25,000 g for 20 min, and the supernatant was removed and saved. The pellet was resuspended in 4% SDS, the resuspension heated at 100°C for 4 min, and then centrifuged at 12,000 g for 5 min. This supernatant, designated as the SDS extract, was removed and saved. All samples were stored at -700C. Protein concentrations were obtained by using the BCA protein assay reagent kit by Pierce Chemical Co., Rockford, IL. In designated experiments, the initial pellet was extracted with 2% deoxycholate before extraction with 4% SDS.
Immunoprecipitation. An aliquot (100-200 Ml) of tissue extract containing 300 Mg protein was added to 800 Ml ofa solution containing 2.5% Triton X-100, 190 mM NaCl, 6 mM EDTA, 50 mM Tris-HCI (pH 7.4), and 0.25 mM PMSF. A goat, anti-human polyclonal antibody to fibronectin (F-1509; Sigma Chemical Co., St. Louis, MO) was added (20 ,l, 660 Mg protein), and the mixture incubated overnight at 4°C. Samples were centrifuged at 12,000 g for 2 min at 4°C and the supernatant was transferred to a clean microcentrifuge tube. 300 Ml ofa 1:1 suspension ofprotein A-Sepharose CL-4B (Pharmacia Fine Chemicals, Piscataway, NJ) was added and incubated using end-over-end mixing at room temperature for 2 h. Samples were then centrifuged for 10 s and the supernatant aspirated. The precipitated beads were washed four times with a solution of 0.1% Triton X-100, 0.02% SDS, 150 mM NaCl, 5 
Results
Preliminary experiments using rat aortic rings showed that rat aortic rings were metabolically active with respect to protein biosynthesis. Fig. 1 Values are means±SEM; * P < 0.05; * P < 0.01; I P < 0.001.
polyclonal antibody directed towards fibronectin. The distribution of newly formed fibronectin among the different fractions was consistently greatest for the fraction obtained using 4% SDS, which comprised -60% of total radiolabeled fibronectin. About 15% was released into the medium, and the remainder was primarily in the deoxycholate extract. Table I summarizes the comparative data on groups ofanimals treated with DOC/salt for 7 or 21 d and the appropriate age-matched controls. Systolic blood pressure was significantly higher in the treated animals even after 7 d (150 vs. 120 mmHg) and by 21 d the DOC/salt-treated group had systolic pressures that averaged 174 mmHg. Both heart weight and aortic weight increased progressively with treatment, and the ratios with respect to body weight were consistently higher in the treated groups. The amount of soluble protein in both the supernatant (from the original aortic homogenate) and SDS extract was consistently greater in hypertensive vessels. This increase was proportionately greater than the increased wet weight and could reflect increased intracellular or extracellular protein.
Comparative studies between normal rat aorta and aortic tissue from hypertensive animals were performed using a protocol where two animals from each group were killed on the same day. The SDS extract obtained immediately after centrifugation of the homogenized tissue, which effectively combined the extracts using deoxycholate and SDS shown in Fig. 1 , was used for the biochemical comparisons shown in Fig. 2 and the subsequent tables. Fig. 2, A, B, and C, shows representative data on "S-methionine incorporation into total protein and immunoprecipitable fibronectin in the aortic SDS extracts of control and 2 1-d treated rats. Each lane contains protein from incubated rings derived from a separate animal. The profile oftotal radioactive protein in the SDS fraction suggests that both high and low molecular weight proteins were made at about equivalent levels in control and DOC-treated animals. However, after immunoprecipitation of fibronectin in those samples, there was an obvious increase in the amount of labeled fibronectin immunoprecipitated from the samples of DOC-treated animals (Fig. 2 B) . Quantitative immunoprecipitation was confirmed by experiments showing that comparable amounts of labeled fibronectin were immunoprecipitated using levels of antibody ranging from 10 to 200% of the amount used under standard conditions (660 jig). This was true using extracts from control or treated animals. If the gels containing the immunoprecipitated samples were stained directly for protein using Coomassie brilliant blue (Fig. 2 C) , it was possible to visualize protein in the region where fibronectin should be localized, particularly in the extracts from treated animals. This further indicated the efficacy of the immunoprecipitation procedure for quantitative analysis. The other bands on the gel are the IgG heavy chain (50 kD) and two other Coomassie-positive bands that were present even if the SDS extract was omitted. the SDS extract, since almost no immunoprecipitable fibronectin was found in the supernatant fraction from control or treated animals. Fig. 3 , A and B, depicts representative data using Western blot analysis to compare aortic fibronectin in control and hypertensive rats. Each lane represents the SDS extract from aortic rings of a single rat. There was a clearly visible increase in aortic fibronectin in the DOC/salt-treated animals after either 7 or 21 d oftreatment. Densitometric analysis ofdata obtained from six animals in each age matched group after only 7 d of DOC/salt treatment showed a three to sixfold increase in immunodetectable fibronectin even though blood pressure levels did not exceed 160 mmHg in the treated rats. After treatment for 21 d, immunodetectable fibronectin remained almost sixfold greater than in nonhypertensive age-matched controls. Fig. 3 C shows a comparison between control and 21 -d treated animals using a monoclonal antibody directed towards the EIIIA region of fibronectin, which is contained only in that alternatively spliced form offibronectin thought to be made by nonhepatic cells and not found circulating in plasma. Again, there was an obvious increase in that form offibronectin in the aortic fraction from DOC/salt-treated animals, but the sensitivity of the method was not sufficient to obtain quantitative data in control samples. The antibody had a very weak cross-reactivity towards purified plasma fibronectin (FN standard), indicating that the increased amounts of fibronectin in the extracts from treated animals did not originate solely from circulating protein.
A series of experiments were performed to determine ifdifferences in fibronectin biosynthesis could be found between the SHR and age-matched control Wistar rats using 10, 20, and 40-wk old animals. Table III summarizes the data obtained.
Differences in blood pressure and heart weight/body weight ratios were as expected, and aortic weight/body weight ratios were consistently greater in the SHR. Total protein biosynthesis in the SDS extract was similar in both strains and when expressed relative to the protein concentration, there were only slight differences as a function of age. A significant difference between control and hypertensive animals with respect to fibronectin biosynthesis was found using 10-wk old animals, with a two to threefold increase being found in the vessels from hypertensive animals, analogous to the findings in the DOC/salt model. There was no significant increase in fibronectin biosynthesis in the SHR of older animals when paired with agematched normotensive controls nor did there appear to be major differences in overall protein biosynthesis. However, there was a striking increase in aortic fibronectin biosynthesis within each strain as the animals aged from 10 to 40 wk, an increase that did not occur in overall protein biosynthesis. Thus, the ratio of fibronectin biosynthesis to total protein biosynthesis for 10-wk old Wistar rats (6.64 X 10-2) was increased fourfold and sixfold in 20 and 40-wk old Wistar animals. These relative changes were not as obvious for the SHR because ofthe higher rate of fibronectin biosynthesis in the 10-wk old animals. Another hypertensive animal model used for these studies involved infusion of angiotensin II at pressor levels using an osmotic pump. This was done for either 3 or 13 d, and the general protocol outlined above for measuring protein and fibronectin biosynthesis was followed. The results are summarized in Table IV . Animals infused with angiotensin II for 13 d were hypertensive and had increased heart and aortic wet weight. Animals infused for 3 d had only slightly elevated blood pressures when measured before killing the animals, but the increased aortic wet weight and a statistically insignificant increase in heart weight suggested that blood pressure levels were chronically elevated during the 3 d of treatment. Both protein and fibronectin biosynthesis increased as a result of angiotensin II infusion at both time periods studied, although interassay variability did diminish the statistical significance of the increase in fibronectin biosynthesis.
Western blot analysis of the aortic SDS extracts from animals infused with angiotensin II showed marked increases in fibronectin content even after only three days of treatment ( Fig. 4 A) . The relative increases as determined by densitometry ranged from three to eightfold at either time ofinfusion and suggested major changes in the aortic extracellular matrix occurred rapidly in response to angiotensin II infusion. These changes also were seen in animals given the peptide for 13 d, although the increases were not as marked as those observed at the earlier time. Comparisons between age-matched Wistar and SHR by Western blot analysis indicated slightly more immunoreactive fibronectin in the 10-wk old animals (Fig. 4 B) , densitometric analysis suggesting a 1.8-fold difference in relative intensity. At 20 and 40 wk of age the changes were less obvious. Differences between age-matched animals at any of the ages examined did not appear nearly as striking as those observed with the DOC/salt-treated animals. However, if the extracts from the same strain were compared as a function of age (Fig. 4 C) , there was a noticeable increase in immunodetectable fibronectin between 10 and 40-wk old animals both in the Wistar and the SHR, consistent with the biosynthetic data shown in Table III . The age-dependent increase did appear more pronounced in the SHR.
Discussion
The in vitro studies presented in this study used metabolically intact aortic rings to compare the biosynthesis offibronectin in normotensive and hypertensive rat models. The aortic rings provided a useful metabolic preparation to assess both total protein biosynthesis and the specific formation ofimmunoprecipitable fibronectin. Steady-state mRNA levels for aortic fibronectin were recently shown to be increased during the course of experimental or genetic hypertension in rats, concomitant with increases in immunodetectable fibronectin (19 Total protein biosynthesis in aortic rings from normotensive and hypertensive models was similar in these in vitro studies when normalized to total protein content. This was somewhat surprising since aortic hypertrophy is a consistent sequela to the hypertensive state (29) , with hypertrophy often being defined as an increase in protein per cell. Using cultured vascular smooth muscle cells, studies have shown that incubation with angiotensin II leads to a hypertrophic response that includes increased protein biosynthesis (30, 31) . One explanation for the similarity in protein biosynthesis between rings could be that the rings are no longer subjected to mechanical forces that exist in vivo, and increased wall tension could be a factor mediating the biochemical differences observed in vivo. Concerning the effect of mechanical forces on protein metabolism, increased mechanical tension on isolated pulmonary artery segments caused increased biosynthesis of collagen and elastin (32) and studies using cultured smooth muscle cells showed that collagen biosynthesis was increased by cyclic stretching (33) .
The differences in aortic fibronectin biosynthesis between control and hypertensive groups were most obvious in the DOC/salt model, and the approximately sixfold increase in biosynthetic rate after 21 d oftreatment is quantitatively similar to the previously reported difference in fibronectin steady-state mRNA levels (19) . Because of the protocol used, we cannot completely rule out the possibility that changes in amino acid uptake, precursor pools, or fibronectin degradation account for the increase in net incorporation of labeled methionine into immunoprecipitable fibronectin. However, the absence of significant differences in net incorporation into total protein does minimize the possibility that differences in uptake or precursor pools affected the results. With respect to fibronectin degradation, we have not directly compared treated and control animals, but in separate experiments using normal aortic tissue, a pulse-chase protocol indicated that the amount of labeled methionine incorporated into fibronectin from the SDS extract during a 4-h pulse was unchanged after a 2, 6, or 24-h chase period. Thus the pool of newly synthesized fibronectin being measured in these studies has a relatively slow turnover.
These data provide evidence that transcriptional events influenced fibronectin biosynthesis in the aorta, and also reinforce the probability that the in vitro biosynthetic data reflect events occurring in vivo. What was unexpected was the finding that immunoreactive fibronectin was increased to such a significant extent, even after only 7 d of DOC/salt treatment, when blood pressure changes were modest. The immunochemical assays measure fibronectin that might originate from circulating plasma as well as from aortic synthesis. Unless fibronectin turnover is rapid in aortic tissue, the large difference between treated and control groups could reflect increased insudation of plasma fibronectin in addition to endogenously produced protein. Using the monoclonal antibody to the alternatively spliced form of fibronectin containing the EIIIA insert, which is known not to circulate in plasma, we were able to show significant increases in endogenously produced material. However, this does not rule out the possibility of infiltration of plasma fibronectin secondary to DOC/salt treatment.
The changes observed with age also showed a reasonable correlation between fibronectin biosynthesis and the previously reported data (19) on steady-state mRNA levels, which increased progressively between 5 and 40 wk ofage. In general, the increased biosynthetic rate for fibronectin with age in both Wistar and SHR was consistent with steady-state mRNA data (19) , and with the findings using Western blot analysis, where increases were seen in the 40-wk old animals compared to those of 10 and 20 wk of age. The similar fibronectin biosynthetic rates between age-matched normotensive and hypertensive animals were in contrast to our previously reported steadystate mRNA data, which suggested approximately two to threefold greater levels in hypertensive animals at the ages studied. This could indicate that posttranscriptional regulatory mechanisms may influence fibronectin biosynthesis as the animals age and the composition ofthe extracellular matrix changes, or it may reflect different regulatory mechanisms for fibronectin expression in the SHR as compared to the Wistar. Interestingly, comparisons of immunodetectable fibronectin between the age-matched strains were more consistent with the biosynthetic data than that for steady-state mRNA, further suggesting the possibility of posttranscriptional control.
Fibronectin is generally considered to have an important role in the process of wound repair, and there are analogies between the vascular response to hypertension and wound repair. Of potential relevance is the regulatory role of growth factors in both processes. Transforming growth factor-(B (TGFfl) was shown to influence fibronectin expression in cultured fibroblasts (34, 35) and is generally thought to influence the wound repair process in vivo, in part by its effects on the extracellular matrix. However, TGF-,3 did not influence collagen or fibronectin expression in cultured smooth muscle cells (36, 37) . We have shown that TGF-f# mRNA levels were increased in aortae ofrats treated with DOC/salt (38) suggesting the possibility of autocrine or paracrine influences on aortic extracellular matrix, but there is no definitive study to date showing that TGF-f modulates aortic gene expression in vivo. Although growth factors clearly have a role in influencing fibronectin expression, many other regulatory agents have been proposed and it is premature to state whether hemodynamic forces, paracrine and autocrine regulation, or intracellular regulatory events have a predominant role within the vessel wall. However, the use of metabolically intact aortic rings that maintain cell to cell and cell to extracellular matrix interactions in a manner which is perhaps more physiological than that present in cell culture, offers a potentially valuable system for determining the factors regulating fibronectin biosynthesis.
